Retlaw - you asked about HALO
HALO announced that the Data Monitoring Committee now supported enrollment in the company's PEGPH20 study for Pamcreatic Camcer. They are still in talks with the FDA and need to wait for the FDA to lift the halt. My guess is that won't be too long in coming. Last night in after hours trading the sp was up about a buck. We will see how it fares in todays regular trading session.